FDA Approved: AUBAGIO — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Aubagio (teriflunomide) by Genzyme Corporation. The submission status is AP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• AUBAGIO (TERIFLUNOMIDE)

Snippet

SUPPL AP for AUBAGIO (TERIFLUNOMIDE)